TMO Thermo Fisher Scientific Inc.
Stable Earnings Power
C+ 60.0 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
D 38
  • 5yr Avg ROIC 8.5%
  • Operating Margin Trend -1.73 pp/yr

Capital Efficiency

Weight: 15%
B+ 76
  • 5yr Avg ROE 12.6%
  • 5yr Share-Count CAGR -1.3%

Growth Quality

Weight: 15%
D+ 42
  • 5yr Revenue CAGR 3.2%
  • 5yr EPS CAGR -2.3%
  • Revenue-Growth Years (5) 4/5

Cash Generation

Weight: 15%
A 91
  • 5yr FCF Margin 16.1%
  • 5yr FCF/NI Conversion 1.03x

Balance Sheet

Weight: 20%
B- 67
  • Net Debt / EBITDA 2.68x
  • Interest Coverage (EBIT/Int) 6.12x
  • Altman Z-Score 3.11

Stability

Weight: 15%
C 52
  • EPS Volatility (σ/μ) 0.47
  • Piotroski F-Score 5
  • Negative-Revenue Years (5) 1/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

6 of 6 gurus held; 1 new buy; 3 added; 2 trimmed; 1 full exit.

Holders
6
Avg Δ position
+159.2%
New buys
1
Full exits
1
As of Q1 2026